The Global Regulatory Advantage Behind UTHEVER® NMN

Overview


EFFEPHARM

Regulatory uncertainty remains one of the biggest challenges for NMN brands. Choosing the wrong ingredient could lead to compliance risks & market restrictions.

UTHEVER® removes the uncertainty. UTHEVER® NMN is FDA NDI-cleared for the U.S. market. In addition, UTHEVER® has obtained regulatory recognition in the EU & Brazil, and NMN is already compliantly sold in Mexico, Japan, HK & Malaysia. This reflects our commitment to product quality and long-term regulatory compliance, helping support your global expansion.

Download the White Paper to discover UTHEVER® NMN’s full range of health benefits & latest clinical evidence, and learn where NMN can be sold compliantly today.

This content is paid by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now


Latest Content

Related Resources

Discover UTHEVER® NMN’s Global Regulatory Landscape

Discover UTHEVER® NMN’s Global Regulatory Landscape

Paid for by Effepharm Ltd

White Paper

NMN has long faced regulatory challenges. Today, that landscape is changing. We consistently invest in scientific research & quality development, aiming to establish UTHEVER® as the world’s most compliant NMN ingredient brand.

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

The Only & 1st NMN Got Novel Food EFSA Positive Safety Opinion

Paid for by Effepharm Ltd

White Paper

On 11th May 2026, EFSA officially published a positive scientific opinion on EffePharm’s β-NMN as a novel food. This is the first-ever EU official safety endorsement for NMN. UTHEVER® is the 1st NMN ingredient brand to receive EFSA’s positive opinion.

Supplier Info Centre

Effepharm-Ltd.jpg

For more product information visit Effepharm Ltd.